These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 27340286)

  • 1. All Things Complement.
    Thurman JM; Nester CM
    Clin J Am Soc Nephrol; 2016 Oct; 11(10):1856-1866. PubMed ID: 27340286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement in glomerular diseases.
    Tan Y; Zhao MH
    Nephrology (Carlton); 2018 Oct; 23 Suppl 4():11-15. PubMed ID: 30298653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement and Complement Targeting Therapies in Glomerular Diseases.
    Andrighetto S; Leventhal J; Zaza G; Cravedi P
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31888179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of complement in kidney disease.
    Petr V; Thurman JM
    Nat Rev Nephrol; 2023 Dec; 19(12):771-787. PubMed ID: 37735215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Rare Inflammatory Kidney Diseases: Drugs Targeting the Terminal Complement Pathway.
    Anliker-Ort M; Dingemanse J; van den Anker J; Kaufmann P
    Front Immunol; 2020; 11():599417. PubMed ID: 33362783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent insights into C3 glomerulopathy.
    Barbour TD; Pickering MC; Cook HT
    Nephrol Dial Transplant; 2013 Jul; 28(7):1685-93. PubMed ID: 23479095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the alternative pathway of complement activation in glomerular diseases.
    Łukawska E; Polcyn-Adamczak M; Niemir ZI
    Clin Exp Med; 2018 Aug; 18(3):297-318. PubMed ID: 29450785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of complement in glomerular diseases.
    Mao S; Zhang J
    J Recept Signal Transduct Res; 2016; 36(3):319-25. PubMed ID: 26400225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of complement in C3 glomerulopathy.
    Zipfel PF; Skerka C; Chen Q; Wiech T; Goodship T; Johnson S; Fremeaux-Bacchi V; Nester C; de Córdoba SR; Noris M; Pickering M; Smith R
    Mol Immunol; 2015 Sep; 67(1):21-30. PubMed ID: 25929733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement and kidney disease.
    Cook HT
    Curr Opin Nephrol Hypertens; 2013 May; 22(3):295-301. PubMed ID: 23508058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the complement cascade: novel treatments coming down the pike.
    Thurman JM; Le Quintrec M
    Kidney Int; 2016 Oct; 90(4):746-52. PubMed ID: 27325183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement and glomerular diseases.
    Popat RJ; Robson MG
    Nephron Clin Pract; 2014; 128(3-4):238-42. PubMed ID: 25412932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecules Great and Small: The Complement System.
    Mathern DR; Heeger PS
    Clin J Am Soc Nephrol; 2015 Sep; 10(9):1636-50. PubMed ID: 25568220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Complement system regulation and C3 glomerulopathy].
    Xiao HJ; He RJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):323-6. PubMed ID: 23591359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement and glomerular disease: new insights.
    Pickering M; Cook HT
    Curr Opin Nephrol Hypertens; 2011 May; 20(3):271-7. PubMed ID: 21422921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary complement biomarkers in immune-mediated kidney diseases.
    Kesarwani V; Bukhari MH; Kahlenberg JM; Wang S
    Front Immunol; 2024; 15():1357869. PubMed ID: 38895123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement inhibitors for kidney disease.
    Wooden B; Tarragon B; Navarro-Torres M; Bomback AS
    Nephrol Dial Transplant; 2023 Nov; 38(Supplement_2):ii29-ii39. PubMed ID: 37218685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies.
    Servais A; Noël LH; Roumenina LT; Le Quintrec M; Ngo S; Dragon-Durey MA; Macher MA; Zuber J; Karras A; Provot F; Moulin B; Grünfeld JP; Niaudet P; Lesavre P; Frémeaux-Bacchi V
    Kidney Int; 2012 Aug; 82(4):454-64. PubMed ID: 22456601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The complement cascade and renal disease.
    Kościelska-Kasprzak K; Bartoszek D; Myszka M; Zabińska M; Klinger M
    Arch Immunol Ther Exp (Warsz); 2014 Feb; 62(1):47-57. PubMed ID: 24030732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The classical pathway triggers pathogenic complement activation in membranous nephropathy.
    Seifert L; Zahner G; Meyer-Schwesinger C; Hickstein N; Dehde S; Wulf S; Köllner SMS; Lucas R; Kylies D; Froembling S; Zielinski S; Kretz O; Borodovsky A; Biniaminov S; Wang Y; Cheng H; Koch-Nolte F; Zipfel PF; Hopfer H; Puelles VG; Panzer U; Huber TB; Wiech T; Tomas NM
    Nat Commun; 2023 Jan; 14(1):473. PubMed ID: 36709213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.